In 2024, the Colorado Prescription Drug Affordability Review Board declared Enbrel unaffordable, and last year it set an ...

Amgen (AMGN) closed at $366.44 in the latest trading session, marking a -2.06% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.72%. Elsewhere, the Dow gained 0.

Healthcare stocks are attractive in a choppy market. These funds, focusing on the broader sector, drugmakers, and biotechs, ...

Here is how Allarity Therapeutics, Inc. (ALLR) and Amgen (AMGN) have performed compared to their sector so far this year.

In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...